Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis
CONCLUSION: MAFLD is common as a sole aetiology, but more so and as a co-factor in mixed-aetiology HCC, supporting the use of a positive diagnostic criteria.PMID:38623613 | DOI:10.3350/cmh.2024.0109 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 16, 2024 Category: Gastroenterology Authors: Harry Crane Guy D Eslick Cameron Gofton Anjiya Shaikh George Cholankeril Mark Cheah Jian-Hong Zhong Gianluca Svegliati-Baroni Alessandro Vitale Beom Kyung Kim Sang Hoon Ahn Mi Na Kim Simone Strasser Jacob George Source Type: research
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against non-alcoholic fatty liver disease
CONCLUSIONS: Ursolic acid could improve immune inflammation in NAFLD by modulating SPP1-mediated Th17 cell differentiation via the ERK signaling pathway, which is orchestrated jointly by ITGB1 and CD44, emerging as a linchpin in this molecular cascade.PMID:38623614 | DOI:10.3350/cmh.2024.0047 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 16, 2024 Category: Gastroenterology Authors: Yiyuan Zheng Lina Zhao Zhekun Xiong Chaoyuan Huang Qiuhong Yong Dan Fang Yugang Fu Simin Gu Chong Chen Jiacheng Li Yingying Zhu Jing Liu Fengbin Liu Yong Li Source Type: research
Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis
CONCLUSION: MAFLD is common as a sole aetiology, but more so and as a co-factor in mixed-aetiology HCC, supporting the use of a positive diagnostic criteria.PMID:38623613 | DOI:10.3350/cmh.2024.0109 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 16, 2024 Category: Gastroenterology Authors: Harry Crane Guy D Eslick Cameron Gofton Anjiya Shaikh George Cholankeril Mark Cheah Jian-Hong Zhong Gianluca Svegliati-Baroni Alessandro Vitale Beom Kyung Kim Sang Hoon Ahn Mi Na Kim Simone Strasser Jacob George Source Type: research
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against non-alcoholic fatty liver disease
CONCLUSIONS: Ursolic acid could improve immune inflammation in NAFLD by modulating SPP1-mediated Th17 cell differentiation via the ERK signaling pathway, which is orchestrated jointly by ITGB1 and CD44, emerging as a linchpin in this molecular cascade.PMID:38623614 | DOI:10.3350/cmh.2024.0047 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 16, 2024 Category: Gastroenterology Authors: Yiyuan Zheng Lina Zhao Zhekun Xiong Chaoyuan Huang Qiuhong Yong Dan Fang Yugang Fu Simin Gu Chong Chen Jiacheng Li Yingying Zhu Jing Liu Fengbin Liu Yong Li Source Type: research
Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
Clin Mol Hepatol. 2024 Apr;30(2):276-278. doi: 10.3350/cmh.2024.0220. Epub 2024 Apr 1.NO ABSTRACTPMID:38606424 | DOI:10.3350/cmh.2024.0220 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Ying-Nan Tsai Jia-Ling Wu Yao-Chun Hsu Source Type: research
Correspondence on Letter regarding "Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study"
Clin Mol Hepatol. 2024 Apr;30(2):281-283. doi: 10.3350/cmh.2024.0214. Epub 2024 Apr 1.NO ABSTRACTPMID:38606425 | DOI:10.3350/cmh.2024.0214 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Hideki Fujii Michihiro Iwaki Yoshihiro Kamada Source Type: research
Correspondence on Letter regarding "Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances"
Clin Mol Hepatol. 2024 Apr;30(2):297-298. doi: 10.3350/cmh.2024.0210. Epub 2024 Apr 1.NO ABSTRACTPMID:38606426 | DOI:10.3350/cmh.2024.0210 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Byoung Kuk Jang Source Type: research
Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
Clin Mol Hepatol. 2024 Apr;30(2):276-278. doi: 10.3350/cmh.2024.0220. Epub 2024 Apr 1.NO ABSTRACTPMID:38606424 | DOI:10.3350/cmh.2024.0220 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Ying-Nan Tsai Jia-Ling Wu Yao-Chun Hsu Source Type: research
Correspondence on Letter regarding "Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study"
Clin Mol Hepatol. 2024 Apr;30(2):281-283. doi: 10.3350/cmh.2024.0214. Epub 2024 Apr 1.NO ABSTRACTPMID:38606425 | DOI:10.3350/cmh.2024.0214 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Hideki Fujii Michihiro Iwaki Yoshihiro Kamada Source Type: research
Correspondence on Letter regarding "Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances"
Clin Mol Hepatol. 2024 Apr;30(2):297-298. doi: 10.3350/cmh.2024.0210. Epub 2024 Apr 1.NO ABSTRACTPMID:38606426 | DOI:10.3350/cmh.2024.0210 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Byoung Kuk Jang Source Type: research
Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
Clin Mol Hepatol. 2024 Apr;30(2):276-278. doi: 10.3350/cmh.2024.0220. Epub 2024 Apr 1.NO ABSTRACTPMID:38606424 | DOI:10.3350/cmh.2024.0220 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Ying-Nan Tsai Jia-Ling Wu Yao-Chun Hsu Source Type: research
Correspondence on Letter regarding "Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study"
Clin Mol Hepatol. 2024 Apr;30(2):281-283. doi: 10.3350/cmh.2024.0214. Epub 2024 Apr 1.NO ABSTRACTPMID:38606425 | DOI:10.3350/cmh.2024.0214 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Hideki Fujii Michihiro Iwaki Yoshihiro Kamada Source Type: research
Correspondence on Letter regarding "Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances"
Clin Mol Hepatol. 2024 Apr;30(2):297-298. doi: 10.3350/cmh.2024.0210. Epub 2024 Apr 1.NO ABSTRACTPMID:38606426 | DOI:10.3350/cmh.2024.0210 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 12, 2024 Category: Gastroenterology Authors: Byoung Kuk Jang Source Type: research
Reply to Correspondence
Clin Mol Hepatol. 2024 Apr 11. doi: 10.3350/cmh.2024.0242. Online ahead of print.NO ABSTRACTPMID:38600869 | DOI:10.3350/cmh.2024.0242 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 11, 2024 Category: Gastroenterology Authors: Atsumasa Komori Source Type: research
Reply to "Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in HBV patients"
Clin Mol Hepatol. 2024 Apr 11. doi: 10.3350/cmh.2024.0228. Online ahead of print.NO ABSTRACTPMID:38600870 | DOI:10.3350/cmh.2024.0228 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 11, 2024 Category: Gastroenterology Authors: Pin-Nan Cheng Ming-Lung Yu Source Type: research
